Antiviral Res. 2010 Jan;85(1):286-94. Epub 2009 Oct 4.

HIV reservoirs, latency, and reactivation: prospects for eradication.

Source

Swedish Institute for Infectious Disease Control, Karolinska Institutet, Nobels väg 18, SE-171 82 Solna, Sweden.

Abstract

Current antiretroviral therapy effectively suppresses but does not eradicate HIV-1 infection. During therapy patients maintain a persistent low-level viremia requiring lifelong adherence to antiretroviral therapies. This viremia may arise from latently infected reservoirs such as resting memory CD4+ T-cells or sanctuary sites where drug penetration is suboptimal. Understanding the mechanisms of HIV latency will help efforts to eradicate the infection. This review examines the dynamics of persistent viremia, viral reservoirs, the mechanisms behind viral latency, and methods to purge the viral reservoirs. This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010.

PMID:: 19808057; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. [Annu Rev Immunol. 2000]
Review Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T, McArthur J, Siliciano RF. Annu Rev Immunol. 2000; 18:665-708.
Review HIV reservoirs and the possibility of a cure for HIV infection. [J Intern Med. 2011]
Review HIV reservoirs and the possibility of a cure for HIV infection.
Palmer S, Josefsson L, Coffin JM. J Intern Med. 2011 Dec; 270(6):550-60. Epub 2011 Oct 27.
Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution. [Top HIV Med. 2005]
Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
Siliciano RF. Top HIV Med. 2005 Aug-Sep; 13(3):96-100.
Review HIV type-1 latency: targeted induction of proviral reservoirs. [Antivir Chem Chemother. 2009]
Review HIV type-1 latency: targeted induction of proviral reservoirs.
Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z. Antivir Chem Chemother. 2009; 19(5):177-87.
Review HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes. [J Leukoc Biol. 2010]
Review HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
Redel L, Le Douce V, Cherrier T, Marban C, Janossy A, Aunis D, Van Lint C, Rohr O, Schwartz C. J Leukoc Biol. 2010 Apr; 87(4):575-88. Epub 2009 Oct 2.

See reviews... See all...

Cited by 6 PubMed Central articles

Nanotechnology and the Treatment of HIV Infection. [Viruses. 2012]
Nanotechnology and the Treatment of HIV Infection.
Parboosing R, Maguire GE, Govender P, Kruger HG. Viruses. 2012 Apr; 4(4):488-520. Epub 2012 Apr 10.
Molecular Understanding of HIV-1 Latency. [Adv Virol. 2012]
Molecular Understanding of HIV-1 Latency.
Abbas W, Herbein G. Adv Virol. 2012; 2012:574967. Epub 2012 Apr 4.
An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1. [Virol J. 2010]
An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1.
Méndez-Ortega MC, Restrepo S, Rodríguez-R LM, Pérez I, Mendoza JC, Martínez AP, Sierra R, Rey-Benito GJ. Virol J. 2010 Dec 20; 7:369. Epub 2010 Dec 20.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

HIV reservoirs, latency, and reactivation: prospects for eradication.
HIV reservoirs, latency, and reactivation: prospects for eradication.
Antiviral Res. 2010 Jan ;85(1):286-94. Epub 2009 Oct 4 .

PubMed
Infective dermatitis of Jamaican children: a marker for HTLV-I infection.
Infective dermatitis of Jamaican children: a marker for HTLV-I infection.
Lancet. 1990 Dec 1 ;336(8727):1345-7.

PubMed
Detection of human mammary tumor virus proteins in human breast cancer cells.
Detection of human mammary tumor virus proteins in human breast cancer cells.
J Virol Methods. 2010 Jan ;163(1):157-61. Epub 2009 Sep 23 .

PubMed
Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV inf...
Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells.
AIDS Res Hum Retroviruses. 1990 Aug ;6(8):1031-7.

PubMed
Unintended spread of a biosafety level 2 recombinant retrovirus.
Unintended spread of a biosafety level 2 recombinant retrovirus.
Retrovirology. 2009 Sep 22 ;6:86.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: